Clinical trial
Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis
NCT01539564 is registered in ClinicalTrials.gov with OraPharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis
- Lead sponsor
- OraPharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- June 30, 2014
- Enrollment
- 215 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.